Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

505 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.
Canet-Hermida J, Marín F, Dorca E, Dueñas N, Costas L, Salinas M, Velasco À, Peremiquel-Trillas P, Paytubi S, Ponce J, Fernández S, Martínez JM, Cárdenas L, Taltavull A, Alemany L, Meléndez C, Oliveras G, Vidal A, Capellá G, López-Bonet E, Brunet J, Matias-Guiu X, Pineda M. Canet-Hermida J, et al. Mod Pathol. 2023 Jul;36(7):100158. doi: 10.1016/j.modpat.2023.100158. Epub 2023 Mar 12. Mod Pathol. 2023. PMID: 36918055
The WID-EC test for the detection and risk prediction of endometrial cancer.
Barrett JE, Jones A, Evans I, Herzog C, Reisel D, Olaitan A, Mould T, MacDonald N, Doufekas K, Newton C, Crosbie EJ, Bjørge L, Colombo N, Dostalek L, Costas L, Peremiquel-Trillas P, Ponce J, Matias-Guiu X, Zikan M, Cibula D, Wang J, Sundström K, Dillner J, Widschwendter M. Barrett JE, et al. Int J Cancer. 2023 May 1;152(9):1977-1988. doi: 10.1002/ijc.34406. Epub 2023 Jan 17. Int J Cancer. 2023. PMID: 36533702 Free article.
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.
Palomero J, Panisello C, Lozano-Rabella M, Tirtakasuma R, Díaz-Gómez J, Grases D, Pasamar H, Arregui L, Dorca Duch E, Guerra Fernández E, Vivancos A, de Andrea CE, Melero I, Ponce J, Vidal A, Piulats JM, Matias-Guiu X, Gros A. Palomero J, et al. J Immunother Cancer. 2022 Dec;10(12):e005443. doi: 10.1136/jitc-2022-005443. J Immunother Cancer. 2022. PMID: 36581331 Free PMC article.
Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding.
Peremiquel-Trillas P, Gómez D, Martínez JM, Fernández-González S, Frias-Gomez J, Paytubi S, Pelegrina B, Pineda M, Brunet J, Ponce J, Matias-Guiu X, Bosch X, de Sanjosé S, Bruni L, Alemany L, Costas L, Díaz M. Peremiquel-Trillas P, et al. Br J Cancer. 2023 Aug;129(2):325-334. doi: 10.1038/s41416-023-02291-1. Epub 2023 May 10. Br J Cancer. 2023. PMID: 37165201 Free PMC article.
Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer.
Pelegrina B, Paytubi S, Marin F, Martínez JM, Carmona Á, Frias-Gomez J, Peremiquel-Trillas P, Dorca E, Zanca A, López-Querol M, Onieva I, Benavente Y, Barahona M, Fernandez-Gonzalez S, De Francisco J, Caño V, Vidal A, Pijuan L, Canet-Hermida J, Dueñas N, Brunet J, Pineda M, Matias-Guiu X, Ponce J, Bosch FX, De Sanjosé S, Alemany L, Costas L. Pelegrina B, et al. EBioMedicine. 2023 Aug;94:104716. doi: 10.1016/j.ebiom.2023.104716. Epub 2023 Jul 20. EBioMedicine. 2023. PMID: 37480623 Free PMC article.
Occupational exposure to pesticides and endometrial cancer in the Screenwide case-control study.
Peñalver-Piñol A, Benavente Y, Frias-Gomez J, Alguacil J, Santibañez M, Contreras-Llanes M, Peremiquel-Trillas P, López-Querol M, Paytubi S, Pelegrina B, Onieva I, Martínez JM, Fernandez-Gonzalez S, Francisco J, Caño V, Brunet J, Pineda M, Ponce J, Matias-Guiu X, Bosch FX, Sanjosé S, Alemany L, Costas L. Peñalver-Piñol A, et al. Environ Health. 2023 Nov 2;22(1):77. doi: 10.1186/s12940-023-01028-0. Environ Health. 2023. PMID: 37919733 Free PMC article.
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.
Vrede SW, Kasius J, Bulten J, Teerenstra S, Huvila J, Colas E, Gil-Moreno A, Boll D, Vos MC, van Altena AM, Asberger J, Sweegers S, van Weelden WJ, van der Putten LJM, Amant F, Visser NCM, Snijders MPLM, Küsters-Vandevelde HVN, Kruitwagen R, Matias-Guiu X, Weinberger V, Reijnen C, Pijnenborg JMA. Vrede SW, et al. JAMA Netw Open. 2022 Dec 1;5(12):e2247372. doi: 10.1001/jamanetworkopen.2022.47372. JAMA Netw Open. 2022. PMID: 36525269 Free PMC article.
FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. Berek JS, et al. Int J Gynaecol Obstet. 2023 Aug;162(2):383-394. doi: 10.1002/ijgo.14923. Epub 2023 Jun 20. Int J Gynaecol Obstet. 2023. PMID: 37337978 Free article.
Response: FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X; FIGO Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. Berek JS, et al. Int J Gynaecol Obstet. 2023 Oct;163(1):331. doi: 10.1002/ijgo.15046. Epub 2023 Aug 7. Int J Gynaecol Obstet. 2023. PMID: 37548599 No abstract available.
505 results